Published on
December 17, 2018
- 12:50 GMT
Arch Therapeutics Receives 510(k) Clearance from the US FDA for AC5™ Topical Gel
FRAMINGHAM, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, today announced that the 510(k) premarket …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
